Finding 1092007 (2023-004)

Material Weakness Repeat Finding
Requirement
L
Questioned Costs
-
Year
2023
Accepted
2024-12-18
Audit: 333283
Organization: Unity Health Care, Inc. (MD)
Auditor: Bdo USA PC

AI Summary

  • Core Issue: The audit and related documents for the year ended December 31, 2023, were not submitted by the September 30, 2024 deadline.
  • Impacted Requirements: The SEFA was not prepared accurately, completely, or on time, violating 2 CFR Section 200.512(a).
  • Recommended Follow-Up: Implement formal policies to track and ensure timely preparation and submission of the SEFA and audit documents.

Finding Text

Criteria: In accordance with 2 CFR Section 200.512(a), the audit must be completed and data collection form and reporting package must be submitted within the earlier of 30 calendar days after receipt of the auditor’s report(s), or nine months after the end of the audit period, adjusted for any extensions permitted by the Office of Management and Budget. Additionally, management is required to prepare a complete and accurate SEFA. Condition: We noted that the audit, reporting package, and data collection form for the year ended December 31, 2023, were not filed by the deadline of September 30, 2024, to the Federal Audit Clearinghouse. Additionally, the SEFA was not accurately, completely, and timely prepared. Cause: The Corporation did not have a formal process in place during the year ended December 31, 2023, to accurately, completely, and timely prepare the SEFA. Effect or Potential Effect: The audit, reporting package, and data collection form for the year ended December 31, 2023, were not accessible to the Federal Audit Clearinghouse in a timely manner and the SEFA was not timely, accurately, or completely prepared. Questioned costs: None Context: The audit, reporting package, and data collection form for the year ended December 31, 2023, was filed untimely to the Federal Audit Clearinghouse. Repeat finding: This is a repeat finding from prior year. This was reported as finding 2022-004 in the 2022 report. Recommendation: We recommend the Corporation adopt policies and procedures, including tracking and monitoring of reporting requirements, to ensure that the SEFA is timely, accurately, and completely prepare and that the audit, reporting package, and data collection form are electronically filed with the Federal Audit Clearinghouse within the applicable deadline. View of Responsible Officials: Due to turnover of several key financial executives and personnel and lack of formal documentation of current policies and procedures, the Corporation was unable to timely prepare the SEFA and related audit documentation.

Categories

Reporting

Other Findings in this Audit

  • 515547 2023-004
    Material Weakness Repeat
  • 515548 2023-005
    Material Weakness Repeat
  • 515549 2023-006
    Material Weakness Repeat
  • 515550 2023-007
    Significant Deficiency Repeat
  • 515551 2023-004
    Material Weakness Repeat
  • 515552 2023-005
    Material Weakness Repeat
  • 515553 2023-006
    Material Weakness Repeat
  • 515554 2023-007
    Significant Deficiency Repeat
  • 515555 2023-004
    Material Weakness Repeat
  • 515556 2023-005
    Material Weakness Repeat
  • 515557 2023-006
    Material Weakness Repeat
  • 515558 2023-009
    Significant Deficiency Repeat
  • 515559 2023-004
    Material Weakness
  • 515560 2023-007
    Significant Deficiency
  • 515561 2023-004
    Material Weakness Repeat
  • 515562 2023-005
    Material Weakness Repeat
  • 515563 2023-006
    Material Weakness Repeat
  • 515564 2023-009
    Significant Deficiency Repeat
  • 515565 2023-004
    Material Weakness Repeat
  • 515566 2023-005
    Material Weakness Repeat
  • 515567 2023-006
    Material Weakness Repeat
  • 515568 2023-009
    Significant Deficiency Repeat
  • 515569 2023-004
    Material Weakness Repeat
  • 515570 2023-005
    Material Weakness Repeat
  • 515571 2023-006
    Material Weakness Repeat
  • 515572 2023-007
    Significant Deficiency Repeat
  • 515573 2023-008
    Significant Deficiency Repeat
  • 515574 2023-009
    Significant Deficiency Repeat
  • 1091989 2023-004
    Material Weakness Repeat
  • 1091990 2023-005
    Material Weakness Repeat
  • 1091991 2023-006
    Material Weakness Repeat
  • 1091992 2023-007
    Significant Deficiency Repeat
  • 1091993 2023-004
    Material Weakness Repeat
  • 1091994 2023-005
    Material Weakness Repeat
  • 1091995 2023-006
    Material Weakness Repeat
  • 1091996 2023-007
    Significant Deficiency Repeat
  • 1091997 2023-004
    Material Weakness Repeat
  • 1091998 2023-005
    Material Weakness Repeat
  • 1091999 2023-006
    Material Weakness Repeat
  • 1092000 2023-009
    Significant Deficiency Repeat
  • 1092001 2023-004
    Material Weakness
  • 1092002 2023-007
    Significant Deficiency
  • 1092003 2023-004
    Material Weakness Repeat
  • 1092004 2023-005
    Material Weakness Repeat
  • 1092005 2023-006
    Material Weakness Repeat
  • 1092006 2023-009
    Significant Deficiency Repeat
  • 1092008 2023-005
    Material Weakness Repeat
  • 1092009 2023-006
    Material Weakness Repeat
  • 1092010 2023-009
    Significant Deficiency Repeat
  • 1092011 2023-004
    Material Weakness Repeat
  • 1092012 2023-005
    Material Weakness Repeat
  • 1092013 2023-006
    Material Weakness Repeat
  • 1092014 2023-007
    Significant Deficiency Repeat
  • 1092015 2023-008
    Significant Deficiency Repeat
  • 1092016 2023-009
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
10.557 Wic Special Supplemental Nutrition Program for Women, Infants, and Children $5.29M
93.224 Community Health Centers $2.85M
93.788 Opioid Str $2.05M
93.217 Family Planning Services $1.47M
93.914 Hiv Emergency Relief Project Grants $1.34M
93.526 Fip Verification $898,419
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $862,759
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $459,480
93.837 Cardiovascular Diseases Research $410,473
93.917 Hiv Care Formula Grants $409,149
93.994 Maternal and Child Health Services Block Grant to the States $328,090
93.427 Provision of Technical Assistance and Training Activities to Assure Comprehensive Cancer Control Outcomes. $113,387
93.426 The National Cardiovascular Health Program $102,468
93.898 Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations $102,041
93.855 Allergy and Infectious Diseases Research $7,112